Eric Coldwell
Stock Analyst at Robert W. Baird
(4.52)
# 1,026
Out of 4,646 analysts
795
Total ratings
58.3%
Success rate
7.5%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACH Accendra Health | Downgraded: Hold | $6 → $1.5 | $1.10 | +36.36% | 73 | Aug 11, 2026 | |
| COR Cencora | Maintained: Buy | $339 → $370 | $310.01 | +19.35% | 75 | Aug 6, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $213 → $291 | $281.27 | +3.46% | 71 | Aug 6, 2026 | |
| MCK McKesson | Maintained: Buy | $941 → $1,015 | $856.69 | +18.48% | 78 | Aug 6, 2026 | |
| MDLN Medline | Maintained: Buy | $45 → $42 | $35.58 | +18.04% | 4 | Aug 6, 2026 | |
| AHCO AdaptHealth | Maintained: Buy | $15 → $10 | $5.70 | +75.44% | 42 | Aug 5, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Buy | $186 → $194 | $167.48 | +15.83% | 71 | Jul 31, 2026 | |
| LH Labcorp Holdings | Maintained: Buy | $334 → $352 | $322.59 | +9.12% | 74 | Jul 31, 2026 | |
| FTRE Fortrea Holdings | Maintained: Buy | $20 → $23 | $17.82 | +29.07% | 15 | Jul 30, 2026 | |
| IQV IQVIA Holdings | Maintained: Buy | $249 → $287 | $241.52 | +18.83% | 68 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $236 → $255 | $236.04 | +8.03% | 61 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $547 → $624 | $581.95 | +7.23% | 60 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $252 → $248 | $231.24 | +7.25% | 69 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 | $94.99 | n/a | 28 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $23 → $22 | $5.00 | n/a | 6 | May 9, 2014 |
Accendra Health
Aug 11, 2026
Downgraded: Hold
Price Target: $6 → $1.5
Current: $1.10
Upside: +36.36%
Cencora
Aug 6, 2026
Maintained: Buy
Price Target: $339 → $370
Current: $310.01
Upside: +19.35%
Charles River Laboratories International
Aug 6, 2026
Maintained: Buy
Price Target: $213 → $291
Current: $281.27
Upside: +3.46%
McKesson
Aug 6, 2026
Maintained: Buy
Price Target: $941 → $1,015
Current: $856.69
Upside: +18.48%
Medline
Aug 6, 2026
Maintained: Buy
Price Target: $45 → $42
Current: $35.58
Upside: +18.04%
AdaptHealth
Aug 5, 2026
Maintained: Buy
Price Target: $15 → $10
Current: $5.70
Upside: +75.44%
ICON Public Limited Company
Jul 31, 2026
Maintained: Buy
Price Target: $186 → $194
Current: $167.48
Upside: +15.83%
Labcorp Holdings
Jul 31, 2026
Maintained: Buy
Price Target: $334 → $352
Current: $322.59
Upside: +9.12%
Fortrea Holdings
Jul 30, 2026
Maintained: Buy
Price Target: $20 → $23
Current: $17.82
Upside: +29.07%
IQVIA Holdings
Jul 29, 2026
Maintained: Buy
Price Target: $249 → $287
Current: $241.52
Upside: +18.83%
Jul 24, 2026
Maintained: Hold
Price Target: $236 → $255
Current: $236.04
Upside: +8.03%
Jul 24, 2026
Maintained: Hold
Price Target: $547 → $624
Current: $581.95
Upside: +7.23%
May 1, 2026
Maintained: Buy
Price Target: $252 → $248
Current: $231.24
Upside: +7.25%
Apr 18, 2022
Maintained: Hold
Price Target: $110
Current: $94.99
Upside: n/a
May 9, 2014
Rated: Buy
Price Target: $23 → $22
Current: $5.00
Upside: n/a